ENXTPA:VIRPPharmaceuticals
Taking Stock Of Virbac (ENXTPA:VIRP) Valuation After Recent Share Price Weakness
Recent share performance and business snapshot
Virbac (ENXTPA:VIRP) has attracted attention after a mixed stretch, with a 1 day gain of 1.8% contrasting with negative returns over the past week, month, and past 3 months.
The veterinary pharmaceuticals group, headquartered in Carros, France, reports annual revenue of €1.43b and net income of €133.03m, with operations spanning Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.
See our latest...